Sam J. Lubner, MD Print Friendly Page
Faculty, University of Wisconsin School of Medicine and Public HealthDr. Lubner graduated from Princeton University, Princeton, NJ, with a BA in History in 1999, and the University of Wisconsin School of Medicine and Public Health (formerly UW Medical School), Madison, WI with a MD, in 2003. His postgraduate internship and residency training in Internal Medicine was performed at Washington University School of Medicine, Barnes-Jewish Hospital, Saint Louis, MO from 2003 to 2006, and a fellowship in Hematology/Oncology at University of Wisconsin Hospital and Clinics, Madison, WI.
Specialties
Clinics
Hospital Affiliation(s)
University Hospital
Veterans Hospital - Wm. S. Middleton Memorial
UW School of Medicine and Public Health
| Department of Medicine |
Professional Certifications and Education
| Board Certification |
Medical Oncology
|
| Fellowship |
University of Wisconsin Hospital and Clinics, Madison, WI
|
| Residency |
Barnes-Jewish Hospital, St. Louis, MO
|
| Internship |
Barnes-Jewish Hospital, St. Louis, MO
|
| Medical School |
University of Wisconsin School of Medicine and Public Health (formerly UW Medical School), Madison, WI
|
| Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000. |
PubMed Articles
-
Weinberg DS Pickhardt PJ Bruining DH Edwards K Fletcher JG Gollub MJ Keenan EM Kupfer SS Li T Lubner SJ Markowitz AJ Ross EA
Computed Tomography Colonography vs Colonoscopy for Colorectal Cancer Surveillance After Surgery. Gastroenterology . 2018 Mar;154(4):927-934.e4
[PubMed ID: 29174927]
-
Lubner MG Stabo N Lubner SJ Del Rio AM Song C Pickhardt PJ
Volumetric Versus Unidimensional Measures of Metastatic Colorectal Cancer in Assessing Disease Response. Clin Colorectal Cancer . 2017 Dec;16(4):324-333.e1
[PubMed ID: 28433601]
-
Pickhardt PJ Edwards K Bruining DH Gollub M Kupfer S Lubner SJ Kim DH Ross E Keenan E Weinberg DS
Prospective Trial Evaluating the Surgical Anastomosis at One-Year Colorectal Cancer Surveillance: CT Colonography Versus Optical Colonoscopy and Implications for Patient Care. Dis Colon Rectum . 2017 Nov;60(11):1162-1167
[PubMed ID: 28991080]
-
Lubner SJ Uboha NV Deming DA
Primary and acquired resistance to biologic therapies in gastrointestinal cancers. J Gastrointest Oncol . 2017 Jun;8(3):499-512
[PubMed ID: 28736637]
-
Thomas MJ Bartlett HL Bassetti MF Lubner SJ Kirvassilis G Anagnostopoulos PV Maloney JD Macke RA
Minimally Invasive Esophagectomy in a Patient With Tetralogy of Fallot and Right-Sided Aortic Arch. Ann Thorac Surg . 2017 Jan;103(1):e77-e79
[PubMed ID: 28007281]
-
Sievers CK Kratz JD Zurbriggen LD LoConte NK Lubner SJ Uboha N Mulkerin D Matkowskyj KA Deming DA
The Multidisciplinary Management of Colorectal Cancer: Present and Future Paradigms. Clin Colon Rectal Surg . 2016 Sep;29(3):232-8
[PubMed ID: 27582648]
-
Jin N Lubner SJ Mulkerin DL Rajguru S Carmichael L Chen H Holen KD LoConte NK
A Phase II Trial of a Histone Deacetylase Inhibitor Panobinostat in Patients With Low-Grade Neuroendocrine Tumors. Oncologist . 2016 Jul;21(7):785-6
[PubMed ID: 27261467]
-
Deming DA Cavalcante LL Lubner SJ Mulkerin DL LoConte NK Eickhoff JC Kolesar JM Fioravanti S Greten TF Compton K Doyle AG Wilding G Duffy A Liu G
A phase I study of selumetinib (AZD6244/ARRY-142866), a MEK1/2 inhibitor, in combination with cetuximab in refractory solid tumors and KRAS mutant colorectal cancer. Invest New Drugs . 2016 Apr;34(2):168-75
[PubMed ID: 26666244]
-
Deming D Uboha N Zafar SY Rosenberg S Bassetti M Glasgow S Borden EC Lubner S
Adjuvant Chemotherapy for Stage II Rectal Cancer. Semin Oncol . 2015 Dec;42(6):e99-107
[PubMed ID: 26615141]
-
Lubner MG Stabo N Lubner SJ del Rio AM Song C Halberg RB Pickhardt PJ
CT textural analysis of hepatic metastatic colorectal cancer: pre-treatment tumor heterogeneity correlates with pathology and clinical outcomes. Abdom Imaging . 2015 Oct;40(7):2331-7
[PubMed ID: 25968046]
-
Tran NH Cavalcante LL Lubner SJ Mulkerin DL LoConte NK Clipson L Matkowskyj KA Deming DA
Precision medicine in colorectal cancer: the molecular profile alters treatment strategies. Ther Adv Med Oncol . 2015 Sep;7(5):252-62
[PubMed ID: 26327923]
-
Makielski RJ Lubner SJ Mulkerin DL Traynor AM Groteluschen D Eickhoff J LoConte NK
A phase II study of sorafenib, oxaliplatin, and 2 days of high-dose capecitabine in advanced pancreas cancer. Cancer Chemother Pharmacol . 2015 Aug;76(2):317-23
[PubMed ID: 26068189]
-
LoConte NK Razak AR Ivy P Tevaarwerk A Leverence R Kolesar J Siu L Lubner SJ Mulkerin DL Schelman WR Deming DA Holen KD Carmichael L Eickhoff J Liu G
A multicenter phase 1 study of γ -secretase inhibitor RO4929097 in combination with capecitabine in refractory solid tumors. Invest New Drugs . 2015 Feb;33(1):169-76
[PubMed ID: 25318436]
-
Lubner SJ Mullvain J Perlman S Pishvaian M Mortimer J Oliver K Heideman J Hall L Weichert J Liu G
A Phase 1, Multi-Center, Open-Label, Dose-Escalation Study of 131I-CLR1404 in Subjects with Relapsed or Refractory Advanced Solid Malignancies. Cancer Invest . 2015;33(10):483-9
[PubMed ID: 26536061]
-
Halverson JL Martinez-Donate AP Palta M Leal T Lubner S Walsh MC Schaaf Strickland J Smith PD Trentham-Dietz A
Health Literacy and Health-Related Quality of Life Among a Population-Based Sample of Cancer Patients. J Health Commun . 2015;20(11):1320-9
[PubMed ID: 26161549]
-
Deming DA Maher ME Leystra AA Grudzinski JP Clipson L Albrecht DM Washington MK Matkowskyj KA Hall LT Lubner SJ Weichert JP Halberg RB
Phospholipid ether analogs for the detection of colorectal tumors. PLoS One . 2014;9(10):e109668
[PubMed ID: 25286226]
-
LoConte NK Holen KD Schelman WR Mulkerin DL Deming DA Hernan HR Traynor AM Goggins T Groteluschen D Oettel K Robinson E Lubner SJ
A phase I study of sorafenib, oxaliplatin and 2 days of high dose capecitabine in advanced pancreatic and biliary tract cancer: a Wisconsin oncology network study. Invest New Drugs . 2013 Aug;31(4):943-8
[PubMed ID: 23263993]
-
Ayvaci MU Shi J Alagoz O Lubner SJ
Cost-effectiveness of adjuvant FOLFOX and 5FU/LV chemotherapy for patients with stage II colon cancer. Med Decis Making . 2013 May;33(4):521-32
[PubMed ID: 23313932]
-
Mohammed TA Holen KD Jaskula-Sztul R Mulkerin D Lubner SJ Schelman WR Eickhoff J Chen H Loconte NK
A pilot phase II study of valproic acid for treatment of low-grade neuroendocrine carcinoma. Oncologist . 2011;16(6):835-43
[PubMed ID: 21632454]
-
Lubner SJ Kunnimalaiyaan M Holen KD Ning L Ndiaye M Loconte NK Mulkerin DL Schelman WR Chen H
A preclinical and clinical study of lithium in low-grade neuroendocrine tumors. Oncologist . 2011;16(4):452-7
[PubMed ID: 21393344]
